Cancer Metabolomics

Cancer is an overwhelming sickness that changes the digestion system of a cell and the encompassing milieu.  in pharmaceutical examination Metabolomics is a generally quick and precise procedure that can be connected with either turning into an inexorably mainstream instrument in the life sciences or in a worldwide way to uncover new learning about organic frameworks.  The Division of Cancer Biology (DCB) bolsters and encourages fundamental examination in every aspect of tumor science at scholastic establishments and exploration establishments over the United States and abroad. Cancer biomarkers in the clinic, to find pathways included in disease that could be utilized for new targets and to screen metabolic biomarkers amid remedial mediation.

 

  • Gene therapy
  • Cancer immunotherapy
  • Metabolic profiling in cancer
  • Active immunotherapies

Related Conference of Cancer Metabolomics

October 10-11, 2022

International Conference on Biosimilars & Pharmaceuticals

Amsterdam, Netherlands
October 24-25, 2022

5th International Conference on Glycobiology

Paris, France
October 27-28, 2022

2nd Annual Summit on Advanced Bionics

Rome, Italy
November 14-15, 2022

4th International Conference on Biochemistry

London, UK
November 14-15, 2022

4th International Conference on Nucleic Acids

London, UK
February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy

Cancer Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in